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Mitochondria isolated from rat heart, liver, kidney and brain (respiratory control 4.0–6.5) release NO and H2O2 at rates that depend on the
mitochondrial metabolic state: releases are higher in state 4, about 1.7–2.0 times for NO and 4–16 times for H2O2, than in state 3. NO release in
rat liver mitochondria showed an exponential dependence on membrane potential in the range 55 to 180 mV, as determined by Rh-123
fluorescence. A similar behavior was reported for mitochondrial H2O2 production by [S.S. Korshunov, V.P. Skulachev, A.A. Starkov, High
protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 416 (1997) 15_18.]. Transition
from state 4 to state 3 of brain cortex mitochondria was associated to a decrease in NO release (50%) and in membrane potential (24–53%), this
latter determined by flow cytometry and DiOC6 and JC-1 fluorescence. The fraction of cytosolic NO provided by diffusion from mitochondria
was 61% in heart, 47% in liver, 30% in kidney, and 18% in brain. The data supports the speculation that NO and H2O2 report a high mitochondrial
energy charge to the cytosol. Regulation of mtNOS activity by membrane potential makes mtNOS a regulable enzyme that in turn regulates
mitochondrial O2 uptake and H2O2 production.
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Mitochondria were recognized as subcellular organelles by
supravital staining by the end of the XIX century and as the
powerhouse of cells, i.e., the sites of the process of oxidative
phosphorylation, in the 1950s with the availability of electron
microscopy and cell fractionation methods. Mitochondrial
isolation permitted the identification of the inner mitochondrial
membrane as the place in which mitochondrial complexes I–V
are constitutive proteins and as the coupling membrane for the
transduction of the redox chemical energy of NADH oxidation
into ATP high-energy phosphate bond. By 1955, Chance andAbbreviations: mtNOS, mitochondrial nitric oxide synthase; NOS, nitric
oxide synthase; L-NMMA, Nω-monomethyl-L-arginine; L-NNA, Nω-nitro-L-
arginine; Rh-123, Rhodamine 123; DiOC6, 3,3′-dihexiloxocarbocyanine iodide;
JC-1, 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl benzimidazolocarbocyanine io-
dide; CCCP, carbonyl cyanide m-chlorophenyl hydrazone
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doi:10.1016/j.bbabio.2006.02.010Williams [1] described the redox states of the components of the
mitochondrial respiratory chain and defined the operational
concepts of mitochondrial metabolic states and respiratory
control. The latter concept elegantly describes the state 4 to state
3 transition in which ADP regulates the rate of mitochondrial
electron transfer and respiration. State 4, with availability of
respiratory substrates but not of ADP and slow rates of O2
uptake, was described as “controlled or resting respiration”;
whereas state 3, with ample respiratory substrate and ADP
availability was defined as the “active respiration”, i.e., the
maximal physiological rate of ATP production and O2
consumption. The linear rates of O2 uptake observed in isolated
tissues and perfused organs have been interpreted as the result
of a fast and random oscillation of mitochondria between states
3 and 4. This physiological condition driven by local ATP
demands results in mitochondrial subpopulations exposed either
to high ATP or ADP levels that decline or stimulate respiration
[2,3]. By the determination of the rates of mitochondrial O2
uptake in states 4 and state 3 and of whole tissue O2 uptake, it
was estimated that in average and under physiological
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whereas 33% are in state 3 [4].
There is a generalized concept that in physiological
conditions, mitochondria provide to the rest of the cell both
energy and signals to command the genetic expression and
metabolic regulation [5]. However, the biochemical mechan-
isms and the molecular signals involved in the cross-
communication and co-regulation of mitochondrial and cyto-
solic functions are not yet clearly understood.
Mitochondria were recognized by Boveris and Chance in
1972–1973 as an active source of hydrogen peroxide (H2O2)
[6,7]. In addition, nitric oxide (NO) production is carried out by
mitochondrial nitric oxide synthase (mtNOS), an isoenzyme of
the NOS family, that requires NADPH, L-arginine, O2 and Ca
2+
for enzymatic activity [8]. The gene encoding mtNOS and the
inmunological reactivity of this protein have not been well
established. Specific reactivity of liver, kidney and thymus
mtNOS with anti-iNOS (and not with anti-eNOS or anti-nNOS)
and of brain mtNOS with anti-nNOS was observed in our
laboratory [9,10]. Concerning heart mtNOS, we described
mitochondria reactivity with anti-iNOS antibodies, in an
experiment in which the post-mitochondrial supernatant NOS
was identified using anti-eNOS antibodies [11]. Hydrogen
peroxide and NO are uncharged molecules, highly diffusible
through biological membranes and suitable for cellular and sub-
cellular signaling. The mechanisms by which NO and H2O2
may regulate genetic expression [3,12,13] and metabolism [14]
and the gradients of NO and H2O2 diffusion between
mitochondria and cytosol are processes that are starting to be
understood.
2. Materials and methods
2.1. Mitochondria isolation and preparation of mitochondrial
membranes
Female Wistar rats (200–220 g) were killed by decapitation and Swiss mice
(20–25 g) were killed by cervical dislocation. All procedures involving animals
were in accordance with the 6344/96 regulation of Argentinian National Drugs,
Food and Medical Technology Administration (ANMAT). The organs were
rapidly removed, washed (dissected when applicable as in kidney and brain
cortex) and homogenized in ice-cold MSTE buffer (0.23 M mannitol, 0.07 M
sucrose, 1 mM EDTA, 10 mM Tris–HCl, pH 7.4) at a ratio of 1 g tissue/9 ml of
MSTE. Homogenates were centrifuged at 700 × g for 10 min to discard nuclei
and cell debris. The supernatant was decanted and centrifuged again at 7000×g
for 10 min to precipitate mitochondria that were then washed and resuspended
with MSTE at a concentration of 20–25 mg protein/ml [6,7,15]. Mitochondria
showed respiratory controls (the ratio of state 3/state 4 respiratory rates) of 4.0–
4.7 with succinate and 4.5–6.5 with malate-glutamate as substrates. Mitochon-
drial membranes, i.e., mitochondrial fragments, were obtained from mitochon-
drial disruption by twice freezing, thawing and homogenization by passage
through a tuberculin syringe and needle.
2.2. Oxygen consumption
Oxygen uptake was determined polarographically with a Clark type
electrode in a 1.5 ml chamber at 37 °C, in an air-saturated (185 μM O2)
respiration medium consisting of 0.23 M mannitol, 0.07 M sucrose, 1 mM
EDTA, 5 mM phosphate buffer, 20 mM Tris–HCl (pH 7.0, 7.4 and 7.8),
different concentrations of MgCl2 (4 mM for liver and brain, 2 mM for kidney or
0 for heart mitochondria), and 0.7–1.0 mg of mitochondrial protein/ml [15]. For
brain mitochondria, 0.2% bovine serum albumin was added to the respirationmedium [16]. Respiratory rates were determined with either 6 mM malate and
6 mM glutamate or 8 mM succinate as respiratory substrates for complex I or
complex II, respectively. State 3 active respiration was established by addition of
0.5 mM ADP. Oxygen uptake is expressed in ng-at O/min mg protein.
2.3. Nitric oxide production and release
Nitric oxide release and production were measured at 37 °C in coupled
mitochondria and in mitochondrial membranes by following at 577–591 nm
(ε=11.2 mM−1 cm−1) the oxidation of oxyhemoglobin (HbO2) to methemo-
globin [9,17].
The suspending medium for coupled mitochondria (0.2–0.5 mg protein/ml)
was the respiration medium added with 30 μM HbO2 heme with respiratory
substrates and ADP as described for respiration measurements. Control
experiments with the addition of 4 μM Cu,Zn-SOD and 0.5 μM catalase were
performed to establish the specificity of the NO reaction with HbO2. The reaction
medium used with mitochondrial membranes (0.5–0.8 mg protein/ml) and with
liver post-mitochondrial supernatant was 50 mM KOH–HEPES (pH 4.5 to
5.5) or 50 mM phosphate (pH 6.5 to 7.5) or 50 mM Tris–HCl (pH 7.5 to 8.5),
1 mM L-arginine, 1 mM CaCl2, 100 μM NADPH, 10 μM dithiothreitol, 4 μM
(400 U/ml) Cu,Zn-SOD, 0.5 μM (3600 U/ml) catalase and 30 μM HbO2 heme.
Controls adding 1 mM Nω-monomethyl-L-arginine (L-NMMA) or Nω-nitro-
L-arginine (L-NNA) as inhibitors of mtNOS were performed in all cases to
consider only L-NMMA/L-NNA sensitive hemoglobin oxidation as due to NO
formation. Addition of NOS inhibitors inhibited by about 90% the rate of HbO2
oxidation both with mitochondria and with mitochondrial membranes [9]. The
absorbance changes that were inhibitable by L-NMMA or L-NNA were
expressed as nmol NO/min mg protein.
2.4. Hydrogen peroxide release
The mitochondrial release of H2O2 was determined fluorometrically in
mitochondrial suspensions (0.1–0.3 mg protein/ml) in metabolic state 4 or 3 by
the scopoletin-horseradish peroxidase assay [18,19] by following the decrease in
fluorescence at 365 nm→450 nm. The reaction medium was 0.23 M mannitol,
0.07M sucrose, 20 mMTris–HCl (pH 7.4), 8 mM succinate or 6 mMmalate and
6 mM glutamate, 0.5 μM Cu,Zn-SOD, 1 μM HRP and 1 μM scopoletin.
Calibration was made using H2O2 (0.05–0.35 μM) as standard to express the
fluorescence changes as nmol H2O2/min mg protein.
2.5. Mitochondrial membrane potential
Mitochondrial membrane potentials (Δψ) were determined by measuring
Rh-123 fluorescence in a fluorometer and DiOC6 and JC-1 fluorescence in a
flow cytometer. Rh-123 assay was performed at 503 nm→527 nm with a
Hitachi F-3010 spectrofluorometer at 37 °C [20–22]. The fluorescence of
0.1 μM Rh-123 in the reaction medium (150 mM sucrose, 4 mM MgCl2, 5 mM
potassium phosphate, 30 mM KOH–HEPES pH 7.0 to 8.0) was determined
before addition of mitochondria and taken as total dye concentration ([Rh-
123]total). Rat liver mitochondria (0.5–0.7 mg/ml) were added to the reaction
medium supplemented with 8 mM succinate, 6 mM glutamate and 6 mMmalate,
0.5 mMADP, 2 μM rotenone, 1 μMoligomycin, or 3 μMCCCP as the condition
required. The fluorescence of the suspension was measured and after a stable
level was reached, the reaction mixture was centrifuged at 15000×g for 5 min to
precipitate mitochondria. The Rh-123 concentration remaining in the media
([Rh-123]out) was calculated from the fluorescence values of the supernatant.
The initial total amount of Rh-123 in the cuvette ([Rh-123]total) and the amount
remaining in the media ([Rh-123]out) were used to calculate by subtraction the
total amount of Rh-123 taken up by mitochondria ([Rh-123]mit). The
concentration of free Rh-123 in the matrix ([Rh-123]in) was calculated using
the following equation, and the binding partition coefficients at 37 °C
(Ki=26 μl/mg, Ko=120 μl/mg) [22]:
½Rh123mit ¼ Ki ½Rh123in þ Ko ½Rh123out
Mitochondrial membrane potentials (negative inside) were calculated by the
electrochemical Nernst–Guggenheim relationship ΔΨ=59 log ([Rh-123]in/
[Rh-123]out).
Table 1
Nitric oxide release from rat heart mitochondria
Addition NO release
(nmol/min mg protein)
Malate-glutamate (state 4) 2.20±0.07
Malate-glutamate+SOD+Catalase 2.36±0.10
Malate-glutamate+ADP (state 3) 1.25±0.04
Malate-glutamate+ADP+SOD+Catalase 1.29±0.07
Succinate (state 4) 2.23±0.06
Succinate+SOD+Catalase 2.16±0.09
Succinate+ADP (state 3) 1.22±0.05
Succinate+ADP+SOD+Catalase 1.35±0.09
Values are means±S.E.M. of 3 independent experiments.
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determined loading isolated mitochondria with DIOC6 and JC-1 and
fluorescence analyzed by flow cytometry. Mitochondria (25 μg/ml) were
incubated at 37 °C for 20 min in the presence of 30 nM DIOC6 or 200 nM
JC-1 in buffer consisting on 0.21 M mannitol, 0.07 M sucrose, 5 mM
HEPES, pH 7.4. Fluorescence changes were determined as FL-1 for DIOC6
and JC-1 [23]. Total depolarization by the protonophore CCCP (0.5 μM) was
used as positive control. Experiments were performed in triplicate in a Becton
Dickinson FACS-Calibur flow cytometer with a 488 nm argon laser and a
diode array detector.
2.6. Chemicals
All the used reagents were from Sigma Chemical Co., St. Louis, MO, USA.
Superoxide dismutase (EC 1.15.1.1) from bovine erythrocytes corresponded to
catalog number S-2515. Catalase (EC 1.11.1.6) from bovine liver corresponded
to catalog number C-30. Human ferrous hemoglobin Ao corresponded to catalog
number H-0267.
2.7. Statistics
Results are reported as mean values±S.E.M. of three to four independent
experiments.
3. Results
3.1. Nitric oxide release from coupled heart mitochondria
The NO release from coupled mitochondria, i.e., the NO
diffusion from mitochondria to the suspending medium, was
determined by following spectrophotometrically the oxidation
of HbO2 in the reaction medium during the 2 initial minutes.Table 2
Oxygen consumption, NO release and H2O2 release from rat heart, liver, kidney and
Organ Substrate O2 consumption
(ng-at O/min mg protein)
State 4 State 3
Heart Malate-glutamate 45±4 248±11
Succinate 92±8 394±35
Liver Malate-glutamate 25±2 162±10
Succinate 58±5 274±20
Kidney Malate-glutamate 42±4 190±11
Succinate 67±7 268±20
Brain Malate-glutamate 15±2 67±4
Succinate 22±3 88±5
Values are means±S.E.M. of 3–6 independent experiments.Table 1 shows the rates of NO release from heart
mitochondria added with malate and glutamate or with
succinate as substrates in the absence (state 4) or in the
presence (state 3) of ADP. The rate of NO release from
coupled heart mitochondria decreased from 2.2 to 1.2 nmol
NO/min mg protein in the transition from state 4 to state 3.
The addition of SOD (to avoid interference by O2
−) and
catalase (to avoid HbO2 oxidation by H2O2) to the reaction
medium did not affect the rate of NO release by heart
mitochondria either in state 4 or in state 3 indicating a
specificity of the NO reaction with HbO2.
3.2. The state 4 to state 3 transition regulates mitochondrial
release of NO and of H2O2
Table 2 shows the rates of O2 consumption and the rates of
NO and H2O2 release from rat heart, liver, kidney and brain
mitochondria in state 4 and in state 3. Mitochondria were well
coupled as indicated by the fast rate of state 3 respiration and
by the respiratory control ratios. It is worth noting that the
slower rates of O2 consumption of the resting respiration
(state 4) were associated to faster rates of NO and H2O2
release, and that the faster rates of O2 consumption of the
active respiration (state 3) were associated to slower rates of
NO and H2O2 release. Respiratory control ratios were in the
4.0–6.5 range, whereas NO release was 1.7–2.0 times faster
in state 4 that in state 3 and H2O2 release was 4–16 times
faster in state 4 than in state 3.
3.3. Mitochondrial NO release depends on membrane potential
The rates of NO release and the inner membrane potentials
were determined in parallel in rat liver mitochondria in
metabolic states 4, 3 and 1 and after addition of agents that
abolish membrane potential (CCCP) and that produce hyper-
polarization (oligomycin). Nitric oxide release showed a very
strong and exponential dependence on mitochondrial mem-
brane potential (Δψ) (Fig. 1). The situation of lowest membrane
potential of uncoupled liver mitochondria minimized NO
release rates (0.48 nmol NO/min mg protein), whereas the
addition of oligomycin maximized NO release (1.4 nmol NO/
min mg protein). Intermediate NO release rates and membranebrain mitochondria in states 4 and 3
NO release
(nmol NO/min mg protein)
H2O2 release
(nmol H2O2/min mg protein)
State 4 State 3 State 4 State 3
2.20±0.07 1.25±0.04 0.80±0.04 0.05±0.01
2.23±0.06 1.22±0.05 0.60±0.03 0.04±0.01
1.32±0.02 0.72±0.1 0.60±0.03 0.10±0.01
1.35±0.05 0.73±0.1 0.50±0.04 0.08±0.01
0.52±0.05 0.31±0.02 0.52±0.05 0.12±0.01
0.73±0.04 0.41±0.05 0.44±0.03 0.10±0.01
0.45±0.04 0.23±0.02 0.40±0.02 0.08±0.02
0.48±0.04 0.24±0.03 0.35±0.03 0.04±0.01
Fig. 1. Exponential relationship between membrane potential (Δψ) and NO (full
line) and H2O2 (dotted line) release in mitochondria. Values are means of liver
mitochondrial NO release, expressed as nmol NO/min mg protein (●); heart
mitochondrial H2O2 release, expressed as percentage (Δ); and Δψ (mV and
percentage). Additions: (1) CCCP, (2) mitochondria in state 1, (3) malate-
glutamate+ADP, (4) succinate+ADP, (5) malate-glutamate, (6) succinate, and
(7) malate-glutamate+oligomycin. Data of H2O2 release taken from Korshunov
et al. [24].
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relationship shown in Fig. 1. This dependence appears more
important at the physiological range of Δψ (150–180 mV)
where small changes of mitochondrial membrane potential
produce marked modifications of mitochondrial NO release.Fig. 2. (A) Histograms of mitochondrial membrane potential measured by flow cyto
potentials were calculated as: state 4 (75%)− state 3u (CCCP) (20%)=55 AU=100%;
(20%)=26 AU=48%. (B) Histograms of mitochondrial membrane potential measure
membrane potentials were calculated as: state 3u (CCCP) (94%)− state 4 (15%)=79
−state 4+Ca2+ (73%)=21 AU=27%. AU: arbitrary units.Considering that the permeability of mitochondrial membranes
to NO is constant, the changes in NO release appear to reflect an
effect of membrane potential in the rate of NO production by
mtNOS. A similar exponential dependence on mitochondrial
membrane potential was reported for mitochondrial H2O2
production by Korshunov et al. [24] and the data is included
in Fig. 1 for a comparative purpose.
Mitochondria isolated from mouse brain cortex were used to
determine respiratory rates, NO release and membrane
potential, this latter using flow cytometry and DiOC6 and JC-
1 as fluorescent probes. The histograms corresponding to the
DiOC6 fluorescence distribution in state 4, state 3, state 4 plus
Ca2+, and state 3u (in the presence of 0.5 μM CCCP) are shown
in Fig. 2A. JC-1 green fluorescence distribution in the same
conditions is shown in Fig. 2B. Transition of isolated brain
cortex mitochondria from state 4 to state 3 showed a respiratory
control of 5.5 and was associated to a NO release decrease of
about 50% and a membrane potential decline of 24–53% (Table
3). The addition of enough Ca2+ to induce the permeability
transition pore (PTP) (200 nmol/mg mitochondrial protein)
slightly increased the respiration of state 4 mitochondria but
markedly decreased both membrane potential and NO release.
The NOS inhibitor L-NNA (1 mM) increased the rates of state 4
and state 3 respiration, as observed before for other NOS
inhibitors [16,19] and had almost no effect in membrane
potential but markedly decreased NO release.
3.4. Effect of pH on mitochondrial membrane potential, NO
release and O2 consumption by liver mitochondria
Oxygen consumption, NO release and mitochondrial
membrane potential were determined in liver mitochondriametry using FL1 DiOC6 relative fluorescence intensity. The relative membrane
state 3 (62%)− state 3u (20%)=42 AU=76%; and state 4+Ca2+ (46%)− state 3u
d by flow cytometry using FL1 JC-1 relative fluorescence intensity. The relative
AU=100%; state 3u (94%)−state 3 (57%)=37 AU=47%; and state 3u (94%)
Table 5
Mitochondrial contribution to cellular NO generation under physiological
conditions
Table 3
Oxygen consumption, NO release and membrane potential in mitochondria from
mouse brain cortex
Condition O2 consumption
(ng-at O/
min mg prot)
NO release
(nmol/
min mg prot)
Δψ(a)
(% of
state 4)
Δψ(b)
(% of
state 4)
State 4 13±1 0.41±0.04 100 100
State 3 71±4 0.20±0.01 76±2 47±3
State 4+Ca2+ 22±2 0.22±0.01 48±2 27±2
State 4+L-NNA 25±2 0.09±0.02 98±2 99±2
State 3+L-NNA 93±2 0.07±0.02 75±2 49±2
6 mM Malate+6 mM glutamate were used as substrates. Additions: 200 nmol/
mg protein Ca2+, and 1 mM L-NNA. Values are means±S.E.M.
Membrane potential determined by flow cytometry using DiOC6 (a) and JC-1
(b) fluorescence probes.
Δψ: FL1 DiOC6 and JC-1 fluorescence, expressed as percentage of the
fluorescence of state 4, as indicated in Fig. 2.
Fig. 3. Effect of pH on liver mtNOS activity (●) determined in mitochondrial
membranes, in comparison to post-mitochondrial supernatant NOS activity (Δ).
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function of extramitochondrial pH in the range 7.0–7.8. Table 4
shows that respiratory control and the ratios of NO release and
mitochondrial membrane potential in states 4 and 3 show
maximal values at pH 7.4, and that the three ratios showed a
parallel behavior. Membrane potential ratios were in a good
correlation with both respiratory control (r2 =0.956; P<0.01)
and NO release ratios (r2 =0.952; P<0.01) suggesting common
regulatory mechanisms for O2 uptake and mitochondrial NO
production.
3.5. Mitochondrial and cytosolic contributions to total cellular
NO production
The activity of liver mtNOS, assayed in mitochondrial
fragments, was maximal at pH 7.4, whereas the NOS activity of
the liver post-mitochondrial supernatant exhibited maximal
activities at pH >8.0 (Fig. 3). The pH profiles clearly identify
two different NOS isoforms located in the mitochondria and in
the cytosol, considering that the post mitochondrial fraction
carries the cytosolic enzymes and fragments of the endoplasmic
reticulum and plasma membranes. Similarly, in heart and brain,
mtNOS and cytosolic NOS exhibit different optimal pH values:
6.5 and 7.4, respectively, for heart [25], and 5.5 and 7.4,
respectively, for brain [16].
The relative contribution of mtNOS and cytosolic NOS to
the total cytosolic, i.e., cellular, NO generation was
approached by comparing the rates of NO diffusion from
mitochondria to the cytosol given in Table 2 and the rates ofTable 4
Effect of pH on the ratios of NO release, O2 consumption and membrane
potential in states 4 and 3 in liver mitochondria
pH NO release ratio
(state 4/state 3
NO release)
Respiratory control
ratio (state 3/state 4
O2 consumption)
Membrane potential
ratio (Δψ state 4/
Δψ state 3)
7.0 1.56±0.10 4.36±0.18 1.02±0.01
7.4 1.85±0.14 4.76±0.14 1.06±0.01
7.8 1.57±0.12 4.10±0.17 1.01±0.01
8 mM succinate was used as substrate. Values are means±S.E.M.cytosolic NO production. The physiological situation for
tissue mitochondria was calculated considering the simulta-
neous oxidation of 3 NADH (malate–glutamate) and 1
succinate with 66% of mitochondria in state 4 and 33% of
mitochondria in state 3 [4]. For the cytosol, the physiological
NO production rate was considered the one determined using
full supplementation of the post-mitochondrial supernatant
with the NOS substrates and cofactors (Table 5). The fraction
of cytosolic NO provided by diffusion from mitochondria
was 61% in heart, 47% in liver, 30% in kidney, and 18% in
brain.
4. Discussion
Isolated mitochondria release NO and H2O2 to the suspend-
ing medium, and supposedly to the cytosol, at rates that largely
depend on the mitochondrial metabolic state. The releases are
higher in state 4, about 1.7–2.0 times for NO and 4–16 times for
H2O2, than in state 3 (Table 2 and Fig. 4). The data support the
speculation that NO and H2O2 are diffusible molecules that
jointly with ATP report a high mitochondrial energy charge to
the cytosol. The diffusion of NO and H2O2 was considered aOrgan NO production
nmol NO/min mg protein nmol NO/min g tissue
Mitochondria Cytosol Mitochondria Cytosol
Heart 1.87±0.04 0.63±0.05 99±2 63±5
Liver 1.11±0.03 0.40±0.07 39±1 44±8
Kidney 0.55±0.02 0.34±0.04 15.4±0.8 36±4
Brain 0.38±0.04 0.34±0.05 6.75±0.8 31±3
The rates of cytosolic fraction NO production were determined at pH 7.0. The
rates of NO production in mitochondria and cytosol multiplied by the amount of
mitochondria and post-mitochondrial supernatant per g of tissue gave the organ
rates in nmol NO/min g tissue.
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and proliferation [3,13,14,26].
It was first observed that the rate of mitochondrial O2
−
production, the stoichiometric precursor of mitochondrial H2O2
was approximately linear with the degree of reduction of the
components of the respiratory chain which are more reduced in
state 4 than in state 3 [6,7]. However, it was later recognized that
ionophores and protophores [27] and membrane potentials
themselves [24,28,29] markedly regulate the rates of H2O2
production. Korshunov et al. [24] advanced the concept of
voltage dependent enzyme activity when they reported an
hyperbolic relationship between membrane potential and H2O2
production in rat heart mitochondria with a threshold value that
exceeds the state 3 ΔΨ level, above which a very strong
increase in H2O2 production takes place. Simultaneously,
Hansford et al. [28] showed that active H2O2 production by
heart mitochondria requires both a high fractional reduction of
Complex I and a high membrane potential. Later, Starkov and
Fiskum, indicated a similar relationship between membrane
potential and NAD(P)H redox state, and H2O2 formation in
brain mitochondria [29].
Nitric oxide at sub-micromolar concentrations exhibit two
main effects on the mitochondrial respiratory chain: the
competitive inhibition of cytochrome oxidase [30–32] and the
stimulation of the O2
− production by inhibition of electron
transfer at complex III [33]. This phenomenon is observed in
isolated mitochondria where supplementation with L-arginine or
with L-NMMA enhance or decrease state 4 H2O2 production
[19].
Nitric oxide shows an active intramitochondrial metabo-
lism with a regulated production by mtNOS and an
utilization by the NO non-enzymatic reactions with O2
−
and ubiquinol (UQH2) [34]. The double (for O2
− and NO)
steady state approach can be applied to have an insight into
NO production rates and steady states. The steady state
implies equal rates of NO production (+d[NO]/dt) andFig. 4. Diagram showing the metabolism of NO and H2O2 in rat liver mitochondria. T
The arrows reaching outside the mitochondria indicate diffusion of H2O2 and NO to t
indicated conditions. QBP: ubiquinone binding protein; NADH-DH: NADH dehydrutilization (−d[NO]/dt). Applied to NO mitochondrial
metabolism, +d[NO]/dt is the rate of NO production by
mtNOS, and −d[NO]/dt is the sum of a utilization term (NO
metabolism in the mitochondrial matrix) and a diffusional
term (NO release) (Eq. (1)):
½þd½NO=dtmtNOS ¼ ½d½NO=dtutilization
þ ½d½NO=dtrelease ð1Þ
The diffusional term was experimentally measured as
mitochondrial NO release (Table 2) and the NO matrix
utilization term (Eq. (2)) was calculated as reported by Poderoso
et al. [34] taking into account the two main NO utilization
reactions: the termination reaction with O2
− to yield peroxyni-
trite (ONOO−) and the reduction by UQH2 to produce nitroxyl
anion (NO−):
½d½NO=dtutilization ¼ ka½O2 ½NO þ kb½UQH2½NO ð2Þ
½d½NO=dtrelease ¼ kc½NO ð3Þ
Eqs. (2) and (3), written for states 4 and 3, and expressed as a
ratio (Eq. (4)), give an useful form that relates ratios of mtNOS
activity, NO steady state levels, NO utilization rates and NO
diffusion rates.
½d½NO=dtmtNOSst4
½d½NO=dtmtNOSst3
=
f½NOst4ðka½O2 st4 þ kb½UQH2st4 þ kcÞg
f½NOst3ðka½O2 st3 þ kb½UQH2st3 þ kcÞg
ð4Þ
The liver mitochondrial NO steady state concentration in
state 3 is calculated as 200 nM from the fraction of state 3 O2
uptake (22%) that is affected by arginine and mtNOS inhibitors,
i.e., the mtNOS functional activity [19,26] and the mathematical
model that describes NO concentrations and cytochrome
oxidase inhibition [32]. The NO steady state level in state 4 is
estimated as 370 nM, considering the 1.85 times higher NOhe values below the symbols indicate physiological steady state concentrations.
he cytosol and the values below H2O2 and NO represent rates of diffusion in the
ogenase; MnSOD: Mn-superoxide dismutase.
541A. Boveris et al. / Biochimica et Biophysica Acta 1757 (2006) 535–542release in state 4 (Table 2). Eq. (4) can be solved by placing
the NO steady states levels and available values as follows:
[UQH2]st 4=2.8×10
−4 M and [UQH2]st 3=1.9×10
−4 M [35];
[O2
−]st 4=3.3×10
−10 M and [O2
−]st 3=0.7×10
−10 M [36];
ka=1.9×10
10 M−1 s−1 [37]; kb=2.1×10
3 M−1 s−1 [34]; and
kc=0.5 s
−1. The diffusion constant (kc) was estimated using
Fick's equation (Eq. (5)) and considering the diffusion
coefficient of NO in erythrocyte membrane (D):
0.4×10−5 cm2 s−1 [38], the width of the double mito-
chondrial membrane (dx): 16 nm, and the whole mito-
chondrial area in 1 mg of protein (1.96×10−8 cm2/
mitochondrion×1.02×1010 mitochondria/mg protein):
½d½NO=dtrelease ¼ kc½NO
¼ ½ðD AÞ=ðV  dxÞ  ½NO: ð5Þ
Solved Eq. (4) indicates a rate of NO production of
0.44×10−6 M s−1 for state 3 and of 2.72×10−6 M s−1 for
state 4, with a six times higher mtNOS activity in state 4 than in
state 3, in a process likely driven by membrane potential, as
follows:
ð6Þ
½d½NO=dtmtNOS−st4=½d½NO=dtmt NOS−st3
¼ 2:72 106M s1=0:44 106M s1 ¼ 6
Then, it is appropriate to consider that mtNOS is a voltage-
dependent enzyme, whose activity is regulated by mitochon-
drial membrane potential. It is interesting to note that up to the
moment two mitochondrial activities, the enzymatic activity of
mtNOS and the production of H2O2 (likely by the auto-
oxidation of ubisemiquinone bound to a complex III protein and
disproportionation of O2
−) have been recognized as sensitive to
mitochondrial membrane potential. It seems that the high
electric field (about 20000 V/cm) regulates the conformation
and reactivity of enzyme that are membrane constitutive
proteins.
Regulation of mtNOS activity by membrane potential in the
range of the change associated to the state 4/state 3 transition
makes mtNOS a highly regulable enzyme that in turn regulates
mitochondrial O2 uptake and H2O2 production. Such regulation
and regulatory properties seem to indicate an important
physiological function for this enzyme.
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